Uguen M, Shell D, Silva M, Deng Y, Li F, Szewczyk M
Nat Commun. 2025; 16(1):1905.
PMID: 39994194
PMC: 11850789.
DOI: 10.1038/s41467-025-57005-3.
Zhang M, Bai J, Yuan H, Duan X, Yu L, Li Y
Cell Death Dis. 2025; 16(1):104.
PMID: 39962068
PMC: 11833140.
DOI: 10.1038/s41419-025-07404-7.
Chandrasekaran T, Choudalakis M, Brohm A, Weirich S, Kouroukli A, Ammerpohl O
Nucleic Acids Res. 2024; 52(22):13690-13705.
PMID: 39540436
PMC: 11662677.
DOI: 10.1093/nar/gkae1053.
Ackloo S, Li F, Szewczyk M, Seitova A, Loppnau P, Zeng H
J Med Chem. 2024; 68(2):1092-1112.
PMID: 39495097
PMC: 11770632.
DOI: 10.1021/acs.jmedchem.4c02010.
Zhang J, Donahue G, Gilbert M, Lapidot T, Nicetto D, Zaret K
Nat Cell Biol. 2024; 26(12):2115-2128.
PMID: 39482359
DOI: 10.1038/s41556-024-01547-z.
H3K14ac facilitates the reinstallation of constitutive heterochromatin in early embryos by engaging Eggless/SetDB1.
Tang R, Zhou M, Chen Y, Jiang Z, Fan X, Zhang J
Proc Natl Acad Sci U S A. 2024; 121(33):e2321859121.
PMID: 39437264
PMC: 11331121.
DOI: 10.1073/pnas.2321859121.
Distinct H3K9me3 heterochromatin maintenance dynamics govern different gene programs and repeats in pluripotent cells.
Zhang J, Donahue G, Gilbert M, Lapidot T, Nicetto D, Zaret K
bioRxiv. 2024; .
PMID: 39345615
PMC: 11429881.
DOI: 10.1101/2024.09.16.613328.
SETDB1 as a cancer target: challenges and perspectives in drug design.
Hassanie H, Penteado A, de Almeida L, Calil R, da Silva Emery F, Costa-Lotufo L
RSC Med Chem. 2024; 15(5):1424-1451.
PMID: 38799223
PMC: 11113007.
DOI: 10.1039/d3md00366c.
asteRIa enables robust interaction modeling between chromatin modifications and epigenetic readers.
Stadler M, Lukauskas S, Bartke T, Muller C
Nucleic Acids Res. 2024; 52(11):6129-6144.
PMID: 38752495
PMC: 11194111.
DOI: 10.1093/nar/gkae361.
Decoding chromatin states by proteomic profiling of nucleosome readers.
Lukauskas S, Tvardovskiy A, Nguyen N, Stadler M, Faull P, Ravnsborg T
Nature. 2024; 627(8004):671-679.
PMID: 38448585
PMC: 10954555.
DOI: 10.1038/s41586-024-07141-5.
Keep quiet: the HUSH complex in transcriptional silencing and disease.
Muller I, Helin K
Nat Struct Mol Biol. 2024; 31(1):11-22.
PMID: 38216658
DOI: 10.1038/s41594-023-01173-7.
SETDB1 Triple Tudor Domain Ligand, (,)-59, Promotes Methylation of Akt1 in Cells.
Uguen M, Deng Y, Li F, Shell D, Norris-Drouin J, Stashko M
ACS Chem Biol. 2023; 18(8):1846-1853.
PMID: 37556795
PMC: 10718286.
DOI: 10.1021/acschembio.3c00280.
Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma.
Bitler B, Bailey C, Yamamoto T, McMellen A, Kim H, Watson Z
Mol Carcinog. 2023; 62(11):1717-1730.
PMID: 37493106
PMC: 10592327.
DOI: 10.1002/mc.23610.
Shaping eukaryotic epigenetic systems by horizontal gene transfer.
Arkhipova I, Yushenova I, Rodriguez F
Bioessays. 2023; 45(7):e2200232.
PMID: 37339822
PMC: 10287040.
DOI: 10.1002/bies.202200232.
Chemical tools targeting readers of lysine methylation.
Ortiz G, Kutateladze T, Fujimori D
Curr Opin Chem Biol. 2023; 74:102286.
PMID: 36948085
PMC: 10264141.
DOI: 10.1016/j.cbpa.2023.102286.
The TUDOR domain of SMN is an H3K79 histone mark reader.
Binda O, Kimenyi Ishimwe A, Galloy M, Jacquet K, Corpet A, Fradet-Turcotte A
Life Sci Alliance. 2023; 6(6).
PMID: 36882285
PMC: 9993015.
DOI: 10.26508/lsa.202201752.
DAXX adds a de novo H3.3K9me3 deposition pathway to the histone chaperone network.
Carraro M, Hendriks I, Hammond C, Solis-Mezarino V, Volker-Albert M, Elsborg J
Mol Cell. 2023; 83(7):1075-1092.e9.
PMID: 36868228
PMC: 10114496.
DOI: 10.1016/j.molcel.2023.02.009.
Targets of histone H3 lysine 9 methyltransferases.
Levinsky A, McEdwards G, Sethna N, Currie M
Front Cell Dev Biol. 2022; 10:1026406.
PMID: 36568972
PMC: 9768651.
DOI: 10.3389/fcell.2022.1026406.
SETDB1 regulates microtubule dynamics.
Hernandez-Vicens R, Singh J, Pernicone N, Listovsky T, Gerlitz G
Cell Prolif. 2022; 55(12):e13348.
PMID: 36330589
PMC: 9715361.
DOI: 10.1111/cpr.13348.
TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway.
Gu H, Zhu S, Peng C, Wei Z, Shen Y, Yuan C
Int J Mol Sci. 2022; 23(17).
PMID: 36077559
PMC: 9456363.
DOI: 10.3390/ijms231710161.